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PENDEKATAN BARU DALAM PENYARINGAN KANSER SERVIK 
MENGGUNAKAN SPEKTROSKOPI FOURIER TRANSFORM INFRAMERAH 
 
ABSTRAK 
 
PENGENALAN: 
Pap smear telah digunakan untuk mengesan petanda awal dan kanser serviks 
sejak 1940-an dan terdapat bukti yang jelas bahawa ujian Pap telah 
menurunkan kadar mortaliti/kematian disebabkan kanser serviks. Malangnya, 
terdapat keputusan negatif palsu yang mampu mencecah sehingga 69%. 
Spektroskopi FTIR digunakan dengan meluas dalam pelbagai bidang industri 
untuk menyukat dan mengesan kompaun kimia. Terbaru, ia digunakan untuk 
mengkaji perubahan struktur pelbagai sel kanser manusia pada peringkat 
molekular.  
 
OBJEKTIF: 
Kajian ini dijalankan untuk menilai spektroskopi FTIR sebagai kaedah baru 
untuk penyaringan kanser serviks sebagai perbandingan dengan ujian sitologi. 
 
METODOLOGI: 
Serpihan serviks diambil dan ditempatkan di dalam medium ThinPrepTM. Untuk 
analisis spektroskopi FTIR, sampel dikeringkan dan dipancarkan dengan 
sinaran infra merah pada frekuensi dari 4000 sehingga 400 cm-1. Data serapan 
dicerap menggunakan spektrometer Spektrum BX II FTIR dan dibandingkan 
dengan bacaan serapan rujukan sampel yang diketahui menggunakan perisian 
spektroskopi FTIR. Bacaan spektroskopi FTIR dibandingkan dengan keputusan 
ujian sitologi. 
 xxii
KEPUTUSAN: 
Spektroskopi FTIR dapat membezakan sel normal daripada sel abnormal pada 
800 sampel yang dikaji. Spektrum normal dicirikan dengan jalur glikogen yang 
jelas/kuat pada 1,029 (±4.5) cm-1, jalur meregang C-O karbohidrat yang agak 
jelas/kuat pada 1,156.4 (±4.7) cm-1 dan jalur asimetrik fosfodiester asid nukleik 
pada 1,234 (±4.60) cm-1. 
 
Spektra abnormal dalam kecerunan berbeza menunjukkan penurunan pada 
intensiti jalur glikogen pada 1,029 (±4.5) cm-1 dan intensiti jalur fosfodiester 
yang lebih jelas/kuat pada 1,234 (±4.6) cm-1. Spektra abnormal juga dilihat 
apabila terdapat anjakan jalur simetri fosfodiester pada 1,078 (±1.6) cm-1 
kepada frekuensi yang lebih tinggi dan penurunan intensiti jalur C-OH pada 
1,156 (±4.7) cm-1. Sensitiviti untuk mengesan sel serviks abnormal adalah 85%, 
spesifisiti 91%, nilai jangkaan positif 19.5% dan nilai jangkaan negatif 99.5%. 
 
KESIMPULAN: 
Melalui kajian ini, kami mendapati bahawa FTIR mungkin berguna untuk 
penyaringan kanser serviks. Teknik ini mudah, pantas dan murah serta tidak 
memerlukan pengawetan dan pewarnaan. Kaedah ini dapat diaplikasi di negara 
yang tidak mempunyai sitopatologis yang mencukupi. Sepanjang pengetahuan 
kami, ini merupakan percubaan pertama menggunakan spektroskopi FTIR 
sebagai kaedah alternatif dalam penyaringan kanser serviks di Malaysia. 
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A NEW APPROACH IN THE SCREENING FOR CERVICAL CANCER USING 
FOURIER TRANSFORM INFRARED (FTIR) SPECTROSCOPY 
 
ABSTRACT 
INTRODUCTION: 
Pap smear has been used successfully to detect precursor and cancer lesions 
of the uterine cervix since 1940s. There is clear evidence that Pap test has 
reduced mortality from cervical cancer. Unfortunately false negative smears 
occur and may reach up to 69%. Fourier transform infrared (FTIR) spectroscopy 
has been utilized to measure and detect chemical compounds in many 
industrial fields. Recently it has been used to study the structural changes of 
cells at the molecular level on various human cancers.  
 
OBJECTIVES: 
This study is to evaluate FTIR spectroscopy as new tool for screening of 
cervical cancer in comparison with cervical cytology. 
 
METHODOLOGY: 
Cervical scrapings were taken by cytobrush and placed in ThinPrepTM medium. 
The samples were dried over infrared transparent matrix. Beam of infrared light 
were directed at the dried samples at frequency from 4000 to 400 cm-¹. The 
absorption data were produced using Spectrum BX II FTIR spectrometer. Data 
were compared with the reference absorption data of known samples using 
FTIR spectroscopy software.  FTIR spectroscopy was compared with cytology 
(gold standard).  
 xxiv
RESULTS: 
FTIR spectroscopy could differentiate normal from abnormal cervical cells in the 
800 samples examined.  The normal spectrum was characterized by strong 
glycogen band at 1,029 (±4.5) cm-¹, relatively strong C-O stretching band of 
carbohydrates at 1,156.4 (±4.7) cm-¹ and relatively weak band of the 
asymmetric phosphodiester stretching modes of nucleic acids at 1,234 (±4.6) 
cm-¹. 
 
The abnormal spectra in different gradients showed a decrease in glycogen 
band intensity at 1,029 (±4.5) cm-¹, a stronger and broader intensity of 
phosphodiester stretching band at 1,234 (±4.6) cm-¹.  Abnormal spectra were 
also seen when there was a shifting of symmetric phosphodiester band at 1,078 
(±1.6) cm-¹ to a higher frequency and a decrease in the intensity of C-OH 
stretching band at 1,156 (±4.7) cm-¹. The sensitivity to detect abnormal cervical 
cells was 85%, specificity 91%, positive predictive value 19.5% and negative 
predictive value of 99.5%. 
 
CONCLUSION: 
With this preliminary study we conclude that FTIR may be a useful tool for 
screening of cervical cancer. The technique is simple, rapid and cheap. The 
cervical scrapings require no fixation or staining. This method could be adopted 
in countries where sufficient number of cytopatholgists is not available. To the 
best of our knowledge this is the first attempt at using an alternative method for 
screening of cervical cancer using FTIR spectroscopy in Malaysia. 
 1
 
 
 
 
 
 
 
 
CHAPTER ONE 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 2
INTRODUCTION 
 
 
 
This work deals with a new screening test, Fourier Transform Infrared 
Spectroscopy (FTIR), an important and new technique for detection of cervical 
cancer at its early stages. Screening for cervical cancer is currently carried out by 
the Papanicolau (PAP) smear test. Squamous and glandular epithelial cells of 
transformation zone are exfoliated using Cytobrush or spatula, fixed in ethanol 
and stained with the Papanicolau stain (Patten, 1978). 
 
Until the early 1990s, cervical cancer was the most frequent neoplastic disease 
among women in developing countries, before breast cancer became the 
predominant cancer. Each year, over 400,000 new cases of invasive cervical 
cancer are diagnosed world wide, representing nearly 10% of all cancers in 
women and was responsible for over 250,000 deaths in 2005 (WHO, 2006). 
 
A definitive diagnosis is obtained by cervical biopsy and examination of the 
stained tissue. The predictive value of a biopsy is higher than that of the Pap test 
because the anatomical arrangement is preserved allowing evaluation of 
pathological features in relation to histological architecture (Yeoh and Chan, 
1997).  
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Cervical disease is classified cytologically using the two-tier Bethesda system for 
Pap smears low- (LSIL) and high-grade squamous intraepithelial lesions (HSIL) 
and the three-tier cervical intraepithelial neoplasia (CIN I,II and III) system for 
surgical samples (LSIL=CIN I, HSIL= CIN II and CIN III) (Cestero, 2006).  
 
Samples diagnosed as CIN II and CIN III, have a higher risk of proceeding to 
carcinoma in situ (CIS). For the past 20 years the presence of high-risk Human 
Papilloma Virus (HPV) genotypes has been associated with cervical dysplasia 
and its progression to cancer. This is now being used as an adjunct to detect 
cervical lesions in conjunction with Pap smear (Solomon et al, 2002). 
 
The previous decade has witnessed the evolution of Fourier transform infrared 
(FTIR) spectroscopy as an independent modality to discriminate between 
diseased and normal tissue. Several comprehensive books and articles outlined 
the field (Pavia et al, 2001).  
 
Early studies reported spectral differences between normal and malignant 
tissues by cytological and histological methods. The essential differences were 
related to changes in glycogen, nucleic acid, and protein content (Wood et al, 
2004). 
 
FTIR spectroscopy is used primarily for qualitative and quantitative analysis in 
chemistry and environmental sciences especially for determining the chemical 
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structure of many inorganic and organic compounds, drugs, pollutants, materials 
evaluation and identification. It is also used in deformulations, forensics purposes 
and measuring the level of purity of a compound (Wood et al, 2004). 
 
This study presents preliminary results obtained from the analysis of 800 FTIR 
spectra obtained for cervical smears. The aim of this study is to demonstrate that 
this new technology can differentiate between different cytological results in 
cervical smears, and distinguish normal from dysplastic and neoplastic samples.  
 
FTIR spectroscopy could be used an alternative to Pap smear, which is known to 
have low sensitivity. The clusters of spectra produced have the potential to be 
used as input data for the development of a diagnostic algorithm based on an 
Artificial Neural Network in future. 
 
This study demonstrates that subtle differences between normal and cancer 
samples can be distinguished spectroscopically. The importance of this study is 
based on the fact that the spectroscopic changes precede the morphological 
changes of carcinogenesis which can be seen under the microscope. 
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1.1 Statement of the current problem 
         
The shortage of trained cytopathologists, cytotechnologists and cytopathology 
laboratory facilities in developing countries, the long period (1-3 months) between 
the Pap screenings and the declaration of the test results (Jeronimo et al, 2005).  
 
Pap test involves examination of the specimens under light microscope which is 
tedious, laborious and time-consuming. Highly skilled personnel are required as 
the reliability of the test depends upon human judgment.  
 
The large variation in sensitivity between 30-80%, due to subjective observation 
was another problem limiting the success of screening program.   
 
With these problems in mind, we embarked on an alternative method of 
screening using FTIR spectroscopy. 
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OBJECTIVES 
 
2.1 General objectives 
 
The aim of this study was to evaluate the utility of a new, rapid, more cost-
effective procedure for cervical cancer screening. 
 
2.2 Specific objectives 
                       
1 To identify and characterize the infrared spectra of normal, pre-malignant 
(LSIL and HSIL) and malignant cervical scrapings. 
2 To study the level of agreement between the results of FTIR 
spectroscopy with liquid based cervical smear cytology (gold standard). 
3 To evaluate effectiveness of Fourier transform infrared FTIR 
spectroscopy in screening for pre-neoplastic lesions of cervical smears. 
  
 
 
2.3 Hypothesis 
 
FTIR spectroscopy is as effective as cervical cytology in detecting precursor 
lesions of cervical cancer. 
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Literature Review 
 
  
3.1 Cervical Cancer 
3.1.1 Background 
 
In 2005, according to WHO projections, over 500,000 new cases of cervical 
cancer were diagnosed, of which over 90% were in developing countries. It is 
estimated that over 1 million women worldwide currently have cervical cancer; 
most of whom have not been diagnosed, or have no access to treatment that 
could cure them or prolong their life.  
 
In 2005, almost 260,000 women died of the disease, nearly 95% of them in 
developing countries (WHO, 2006), making cervical cancer one of the gravest 
threats to women’s lives.  
 
In many developing countries, access to health services is limited and 
screening for cervical cancer either is non-existent or reaches few of the women 
who need it. In these areas, cervical cancer is the most common cancer in 
women and the leading cause of cancer death among women (WHO, 2006). 
 
3.1.2 Burden of suffering 
 
Cervical cancer has a major impact on women's lives worldwide, particularly in 
developing countries where it is the leading cause of cancer deaths among 
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women. Four out of five new cases, and a similar proportion of deaths, occur in 
developing countries where screening programs are not well established or 
effective. 
 
Experience in developed countries has shown that well planned, organized 
screening programs with high coverage can significantly reduce the number of 
new cases of cervical cancer and the mortality rate associated with it.  
 
There is also evidence that general awareness about cervical cancer, effective 
screening programs, and the improvement of existing health care services can 
reduce the burden of cervical cancer for women and for the health care system. 
There is a huge difference in the incidence of and mortality from cervical cancer 
between developed and developing countries, as shown in figures 3.1 and 3.2 
(WHO, 2006). 
 
 
 
Fig. 3.1 Age-standardized incidence rates of cervical cancer in developed 
and developing countries for the year 2005 (WHO, 2006) 
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Fig. 3.2 Age-standardized mortality rates of cervical cancer in developed 
and developing countries for the year 2005 (WHO, 2006) 
 
 
 
 
 
The hardest-hit regions are among the world's poorest. Central and South 
America, the Caribbean, sub-Saharan Africa, and parts of Oceania and Asia 
have the highest incidence rates over 30 per 100,000 women. These rates 
compare with no more than 10 per 100,000 women in North America and 
Europe.  
 
Because the disease progress over many years, an estimated 1.4 million 
women worldwide are living with cervical cancer, and two to five times more –up 
to 7 million worldwide –may have precancerous conditions that need to be 
identified and treated. 
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If it is not detected and treated early, cervical cancer is nearly always fatal. The 
disease, which affects the poorest and most vulnerable women, sends a ripple 
effect through families and communities that rely heavily on women's roles as 
providers and caregivers. 
 
3.1.3   Etiology 
3.1.3 (a) Human Papillomavirus (HPV) 
 
Epidemiologic and clinical data indicate that HPV, especially HPV-16 and HPV-
18, play a major role in the etiology of cervical cancer (De Marco et al, 2006). 
Expression of HPV-specific oncoproteins, E6 and E7, are considered essential 
in maintaining malignant growth of cervical cancer cells (Nubia et al, 2006).  
 
However, HPV infections are widespread in the general population yet cannot 
be found in every patient with cervical cancer, nor do all infections with HPV 
result in cervical cancer. There are many investigators who argue that HPV is 
necessary etiologic factor, but few who maintain that it alone is sufficient to 
cause cervical cancer (Zur Hausen, 2002). 
 
In the 1970s, Harald zur Hausen postulated a role for, and then found HPV-
DNA in cervical cancers. In the 1980s, his group was the first to isolate HPV-16 
and HPV-18 from cervical cancer tissues. Several epidemiologists have 
subsequently shown highly statistically significant associations between HPV 
and development of cervical intraepithelial neoplasia (CIN) grade 2 or 3, and 
with development of cervical cancer (Zur Hausen, 2002). 
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In 1995, a World Health Organization consensus panel collected biologic and 
epidemiologic data and concluded that at least HPV-16 and HPV-18 infection 
caused cervical cancer. HPV can be found in more than 90% of patients with 
cervical cancer worldwide, most frequently HPV-16 (50%), HPV-18 (12%), 
HPV-45 (8%), and HPV-31 (5%) (Schiffman and Brinton, 1995).  
 
HPV is DNA tumor virus whose genome is organized in three regions: the early 
gene (E1 to E7), the late gene (L1 and L2) regions and the upper regulatory 
region (URR). The early and late gene regions are both protein-encoding, but 
the URR is non-encoding (Aggarwal et al, 2006).  
 
The URR has numerous binding sites for many repressors and activators of 
transcription, and it may play a part in determining the range of hosts for 
specific HPV types. 
 
In the protein-encoding regions, the E6 and E7 are considered to play the most 
major roles. These two units encode for oncoproteins that allow replication of 
the virus, increasing genomic instability, accumulation of oncogene mutations, 
further loss of cell-growth control, and ultimately cancer. 
 
Both the E6 and E7 proteins alter the pathways that regulate tissue growth, by 
interfering with growth receptors or growth factors. Production of cytokines has 
been shown to be altered in cells infected with HPV-16. The E6 protein 
increases degradation of the p53 tumor suppressor protein, thereby interfering 
with apoptosis (programmed cell death).  
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The E7 protein disrupts complexes of the transcription factor E2F with the 
tumor-suppressor protein pRb and related proteins which are involved in control 
of the cell cycle, thus causing their degradation, altering control of transcription 
and progression of the cell cycle. The E7 protein has been shown to cause 
abnormal synthesis and duplication of centrosomes, resulting in abnormal 
mitotic division (Peter et al, 2006). 
 
The late region units, L1 and L2 encode for viral capsid proteins during the late 
stages of virion assembly. The protein encoded by L1 is highly conserved 
among different papilloma virus species; therefore, antibodies against the 
bovine papilloma virus have been used to identify HPV capsid proteins in 
human tissues.  
 
The minor capsid protein encoded by L2 has more sequence variations than 
that of the L1 protein; hence, antibodies against the L2 protein had been a 
source of antigen for specific types of HPV antibodies (Ho et al, 2006). 
 
 HPVs vary genetically not only between but also within types. Intra-type 
variants are defined as HPVs that vary by 2% or less in specified regions of the 
genome (Cheah, 1994). 
 
Previous studies have reported intra-type sequence variations of the most 
common type, HPV-16, and have included specimens from different geographic 
areas. The major groupings of HPV-16 variants are designated European (E), 
Asian (As), Asian American (AA), African 1 (Af1), African 2 (Af2), and North 
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American 1 (NA1). Variants of these groups are denoted by HPV-16 E6 
nucleotide position and substituted nucleotide (Wheeler et al, 1997). 
 
3.1.3 (b) Sexually transmitted disease (STD) 
 
The specific role of other infectious agents in the pathogenesis of cervical 
cancer has been investigated in many epidemiological surveys. The most 
studied sexually transmitted infectious agents in relation to cervical cancer are 
Herpes Simplex Virus (HSV-2), Chlamydia Trachomatis (CT) and Human 
Immunodeficiency Virus (HIV). Repeated exposure of the uterine cervix to the 
male partner's asymptomatic urogenital infection can lead to precancerous or 
cancerous lesions.  
 
Zur Hausen was also the first to recognize that HPV was not sufficient for 
cancer induction, and proposed that HSV-2 and HPV act synergistically to 
induce cervical cancer (Zur Hausen, 2002).  
 
Others have postulated a role for HSV-2 infection in the etiology of cervical 
cancer, while acknowledging the primary role for HPV, Hildesheim and 
colleagues studied women with invasive cervical cancer in Latin America and 
compared viral and behavioral characteristics with controls.  
 
Compared with women negative for both HPV 16/18 and HSV-2, those positive 
for HSV-2 alone had a relative risk of 1.2. Those positive for HPV 16/18 DNA 
alone had a relative risk of 4.3 (95% CI=3.0, 6.0), and those positive for both 
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HSV-2 and HPV 16/18 had a relative risk of 8.8 (95% CI= 5.9, 13.0), suggesting 
a possible biological interaction. Furthermore, HSV-2 was persistent in a few 
selected cervical cancer tumors (Hildesheim et al, 1991). 
 
Chlamydia trachomatis was associated with a two-fold increased risk for 
cervical cancer (OR=1.8; 95% CI, 1.2-2.7) in the large IARC multi- center case-
control study. It was likely due to the inflammatory response with generation of 
free radicals and development of genetic instability (Smith et al, 2004). 
 
Immunocompromised patients with HIV infection or organ transplantation are at 
high risk of HPV-associated anogenital cancers compared with age matched 
healthy individuals. HIV-positive women are at an increased risk of cervical 
cancer when compared with their HIV-negative counterparts.  
 
This association appears to be stronger for women with a low CD4 T-
lymphocyte count. As HIV infection is related to an immunocompromised state, 
it shows the importance of the host’s immunological cofactors in HPV 
carcinogenesis (Alcina et al, 2005). 
 
3.1.3 (c) Nutritional factors 
 
The few published studies assessing the role of diet on HPV persistence have 
shown a possible protective effect of diets rich in fruits, vegetables, Vitamins C 
and E, beta- and alpha-carotene. Evidence for a protective effect against 
cervical neoplasia was probable for folate, retinol, and Vitamin E, and possible 
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for vegetables, Vitamins C and B12, alpha-carotene, beta-carotene. Evidence 
for an increased risk of cervical neoplasia associated with high blood 
homocysteine was considered probable (Anna, 2000). 
 
The current available evidence for an association between diet, nutritional 
status and cervical HPV carcinogenesis is not yet convincing, even though 
there is some support for the hypothesis that antioxidant nutrients may play a 
protective role in cervical carcinogenesis. 
 
3.1.3 (d) Oral contraceptives and IUDs 
 
The effects of oral contraceptives on the occurrence of cervical neoplasia are 
controversial (Smith et al, 2003). Cervical carcinogenesis may be hormone-
dependent as judged by:  
(a) the histological sensitivity of the cervix to hormonal influences 
(b) the decreasing incidence of cervical cancer after menopause; and 
(c) the results of animal experiments with estrogens and progesterones 
 
Oral contraceptives cause atypical squamous epithelium, increase squamous 
metaplasia, basal cell and glandular hyperplasia of the cervix that could be 
misdiagnosed as malignant, but proved to be benign by using light and electron 
microscopy. Prolonged usage of an intrauterine device (IUD) is often associated 
with exfoliation of atypical cells that might be mistaken to represent carcinoma 
(Lech and Ostrowska, 2006). 
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3.1.3 (e) Genetic aspects 
 
Several structural aberrations were observed in the chromosomes of patients, 
e.g. deletions and marked variability in size and shape of homologous 
chromosomes (Kate et al, 2004). The consistently observed chromosomal 
abnormalities in different stages of carcinoma of the cervix confirm the 
diagnostic value of the presence of such aberrations in cases of equivocal 
diagnosis. Thus, the presence of an abnormal clone of cells with chromosomal 
aberrations may indicate the presence of malignancy (Harry, 2005).  
 
3.1.3 (f) Other risk factors 
 
Tar-based vaginal douching may have a role with the development of cervical 
cancer. In 1931, Smith reported use of Lysol douches was significantly more 
common among cases than among controls. In 1950, Lombard and Potter 
discovered that douching with coal-tar derivatives was reported by more 
cervical cancers cases than controls (Lombard and Potter, 1950).  
 
In 1967, Rotkin found a significant association between Lysol vaginal douches 
and cervical cancer compared with hospital-based controls matched for age, 
race, religion, and hospital (Rotkin, 1973).  
 
Cigarette smoking also plays a role with cervical carcinogenesis. In 1977, 
Winkelstein reached a conclusion that cigarette smoking was a causative factor 
for cervical cancer (Harry, 2004). Other groups of investigators at John Hopkins 
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University have published data supporting passive cigarette smoking as a risk 
factor for cervical cancer (Winkelstein, 1977). 
 
Another carcinogens generated by burning wood in kitchen stoves or ovens are 
tar-based compound and correlated with cervical cancer. In a follow-up study by 
a group of investigators, 125 women with CIN (CIN I, II, III) in Honduras were 
compared with 241 controls.  
 
They concluded that chronic exposure to wood smoke significantly increased 
the risk of CIN III, and that chronic inhalation of carcinogens derived from wood 
smoke could have an effect on the progression to cervical cancer, similar to that 
observed from cigarette smoking (Winkelstein, 1977). 
 
The natural history and risk factors that influence acquisition of persistent HPV 
infection that mediate progression in the continuum of cervical lesion grades is 
shown in the figure 3.3 (Bosch et al, 1997). 
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        Fig. 3.3 Diagram represents a current understanding of cervical 
cancer natural history (Bosch et al, 1997) 
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3.1.4 Epidemiologic Studies 
 
The first observations relating to the incidence, distribution and possible 
causative factors of carcinoma of the uterine cervix were made in 1842 by 
Rigoni-Stern, an Italian physician who examined the records of deaths in 
Verona from 1760 to 1839. He noted that uterine cancer was less common in 
unmarried women and extremely rare in nuns (Hafez, 1982). 
 
Uterine cancer was one of the most prevalent neoplasms reported in Western 
Europe during the mid 19th century. It is thought that the cervix was the primary 
site in most of these cases. An increased risk was noted in the lower 
socioeconomic classes, among multiparous women and in non-white women 
(WHO, 2002).  
 
Previous studies on Jewish and non-Jewish populations conducted in USA, 
Europe indicated that Jewish women had a decreased incidence of cervical 
cancer despite being a part of the lower socioeconomic classes residing in New 
York City (Ezra et al, 2000).  
 
The inference that circumcision of the Jewish males maybe a contributing factor 
prompted the examination of other ethnic groups such as Muslims, who also 
practice circumcision. The results of these investigations suggest that the 
variation in incidence between the compared ethic groups cannot be attributed 
solely to circumcision but maybe due to associated cultural differences or other 
factors (Das et al, 2000). 
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The incidence of carcinoma of the cervix seems to be associated with low 
income and limited education, meanwhile in most countries of the Middle East 
conservative Muslim mode of life, male circumcision, sexual conservatism, and 
ritual hygiene probably operate in reducing incidence of carcinoma whereas 
aesthetic factors and complacency in seeking medical advice operate in 
delaying diagnosis (Fadua, 2001; Wang, 2004). 
 
 
3.1.5 Cancer of the cervix in Malaysia 
 
In 2004, the national Cancer Registry reported that cancer of the cervix was the 
second most common cancer among women in Malaysia for the year 2003 
(Figure 3.4). It constituted 12.9% of total female cancers (NCR website, 
accessed on January 2006).  
   
Cancer cervix was the eighth leading cause of death among medically certified 
deaths in 1998. Nearly 80% of patients with cervical cancer seen with advanced 
stages of IIB - IV A3. Despite the availability of screening program, 10.5% of 
female cancer deaths at government hospitals are due to cervical cancer, 
meanwhile 7.9% of all cancer admissions in government hospitals are 
diagnosed as cervical cancer (Othman, 2003). 
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Fig. 3.4 Ten most frequent cancers in females, Peninsular Malaysia 
2003 (Othman, 2003) 
 
 
 
 
There were a total of 1,557 cases of cancer cervix, with an ASR of 19.7 per 
100,000 population (Table 3.1).  
 
 
Table 3.1 Cervix uteri cancer incidence per 100,000 population (CR) 
and Age- standardized incidence (ASR), Peninsular 
Malaysia 2003 (Othman, 2003) 
 
Sex               No.              %                 CR                 ASR 
Female        1557        100            16.5           19.7 
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Cervical cancer incidence rate increased with age after 30 years. It has a peak 
incidence rate at ages 60-69 years, and declined thereafter (Figure 3.5).  
 
 
 
 
 
Fig. 3.5 Cervix uteri Age- specific cancer incidence per 100,000           
population, Peninsular Malaysia 2003 (Othman, 2003) 
 
Chinese women had the highest ASR of 28.8 per 100,000 population, followed 
by Indians with ASR of 22.4 per 100,000 population and Malays with ASR of 
10.5 per 100,000 population (Table 3.2). 
 
 
 
 
